Enhancing Targeted Therapy in Breast Cancer by Ultrasound-Responsive Nanocarriers
International Journal of Molecular Sciences · 13.03.2023 · 24 (6) · 5474
DOI: 10.3390/ijms24065474 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.03.2023. Verfasst von Isaiah A Edwards und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, University of Mississippi Medical Center, Jackson, MS 39216, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 230 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences of the National Institutes of Health.
Abstract (Originalsprache)
Currently, the response to cancer treatments is highly variable, and severe side effects and toxicity are experienced by patients receiving high doses of chemotherapy, such as those diagnosed with triple-negative breast cancer. The main goal of researchers and clinicians is to develop new effective treatments that will be able to specifically target and kill tumor cells by employing the minimum doses of drugs exerting a therapeutic effect. Despite the development of new formulations that overall can increase the drugs’ pharmacokinetics, and that are specifically designed to bind overexpressed molecules on cancer cells and achieve active targeting of the tumor, the desired clinical outcome has not been reached yet. In this review, we will discuss the current classification and standard of care for breast cancer, the application of nanomedicine, and ultrasound-responsive biocompatible carriers (micro/nanobubbles, liposomes, micelles, polymeric nanoparticles, and nanodroplets/nanoemulsions) employed in preclinical studies to target and enhance the delivery of drugs and genes to breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
- Department of Pharmacology and Toxicology, Cancer Center and Research Institute, University of Mississippi Medical Center, Jackson, MS 39216, USA.
ORCID-Profile: Juliana Sitta, Candace M Howard, Pier Paolo Claudio
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences of the National Institutes of Health
Zitieren
APA
Edwards, I. A., De Carlo, F., Sitta, J., Varner, W., Howard, C. M., & Claudio, P. P. (2023). Enhancing Targeted Therapy in Breast Cancer by Ultrasound-Responsive Nanocarriers. International Journal of Molecular Sciences, 24(6), 5474. https://doi.org/10.3390/ijms24065474
Vancouver
Edwards IA, De Carlo F, Sitta J, Varner W, Howard CM, Claudio PP. Enhancing Targeted Therapy in Breast Cancer by Ultrasound-Responsive Nanocarriers. International Journal of Molecular Sciences. 2023;24(6):5474. doi:10.3390/ijms24065474
BibTeX
@article{Edwards2023,
author = {Edwards, Isaiah A and De Carlo, Flavia and Sitta, Juliana and Varner, William and Howard, Candace M and Claudio, Pier Paolo},
title = {Enhancing Targeted Therapy in Breast Cancer by Ultrasound-Responsive Nanocarriers},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5474},
doi = {10.3390/ijms24065474}
}
EUVIMED